| group | dose | n | pathological grading | Mean | |||||
| - | + | ++ | +++ | ++++ | Rank | ||||
| medium control | - | 5 | 4 | 1 | 0 | 0 | 0 | 8.90 | |
| DMSO control | - | 5 | 5 | 0 | 0 | 0 | 0 | 7.00 | |
| TTE | 10 μg・ml−1 | 3 | 1 | 1 | 1 | 0 | 0 | 16.00 | |
|
| 40 μg・ml−1 | 3 | 0 | 1 | 2 | 0 | 0 | 21.83* | |
|
| 160 μg・ml−1 | 3 | 0 | 0 | 3 | 0 | 0 | 24.50** | |
|
| 640 μg・ml−1 | 3 | 0 | 0 | 0 | 2 | 1 | 31.83* | |
| triptolide | 4 ng・ml−1 | 3 | 2 | 1 | 0 | 0 | 0 | 10.17 | |
|
| 16 ng・ml−1 | 3 | 0 | 2 | 1 | 0 | 0 | 19.17* | |
|
| 64 ng・ml−1 | 3 | 1 | 0 | 1 | 1 | 0 | 20.83 | |
|
| 256 ng・ml−1 | 3 | 0 | 0 | 2 | 0 | 1 | 27.50* | |